nodes	percent_of_prediction	percent_of_DWPC	metapath
Iohexol—Motor dysfunction—Methotrexate—muscle cancer	0.0501	0.0501	CcSEcCtD
Iohexol—Meningism—Methotrexate—muscle cancer	0.0419	0.0419	CcSEcCtD
Iohexol—Blindness transient—Methotrexate—muscle cancer	0.0398	0.0398	CcSEcCtD
Iohexol—Reaction gastrointestinal—Methotrexate—muscle cancer	0.0218	0.0218	CcSEcCtD
Iohexol—Extravasation—Dactinomycin—muscle cancer	0.0192	0.0192	CcSEcCtD
Iohexol—Extravasation—Vincristine—muscle cancer	0.0172	0.0172	CcSEcCtD
Iohexol—Laryngospasm—Etoposide—muscle cancer	0.0163	0.0163	CcSEcCtD
Iohexol—Extravasation—Etoposide—muscle cancer	0.0139	0.0139	CcSEcCtD
Iohexol—Pain in extremity—Vincristine—muscle cancer	0.0109	0.0109	CcSEcCtD
Iohexol—Cardiac arrest—Vincristine—muscle cancer	0.0103	0.0103	CcSEcCtD
Iohexol—Swelling—Etoposide—muscle cancer	0.00998	0.00998	CcSEcCtD
Iohexol—Muscular weakness—Vincristine—muscle cancer	0.00959	0.00959	CcSEcCtD
Iohexol—Anaphylactoid reaction—Etoposide—muscle cancer	0.0091	0.0091	CcSEcCtD
Iohexol—Thrombosis—Doxorubicin—muscle cancer	0.00889	0.00889	CcSEcCtD
Iohexol—Cardiac arrest—Etoposide—muscle cancer	0.00838	0.00838	CcSEcCtD
Iohexol—Extravasation—Methotrexate—muscle cancer	0.00833	0.00833	CcSEcCtD
Iohexol—Bone disorder—Methotrexate—muscle cancer	0.00805	0.00805	CcSEcCtD
Iohexol—Feeling hot—Doxorubicin—muscle cancer	0.00802	0.00802	CcSEcCtD
Iohexol—Flushing—Dactinomycin—muscle cancer	0.00781	0.00781	CcSEcCtD
Iohexol—Injection site pain—Doxorubicin—muscle cancer	0.00771	0.00771	CcSEcCtD
Iohexol—Bronchospasm—Etoposide—muscle cancer	0.00749	0.00749	CcSEcCtD
Iohexol—Urinary tract disorder—Vincristine—muscle cancer	0.00743	0.00743	CcSEcCtD
Iohexol—Urethral disorder—Vincristine—muscle cancer	0.00737	0.00737	CcSEcCtD
Iohexol—Erythema—Dactinomycin—muscle cancer	0.00733	0.00733	CcSEcCtD
Iohexol—Extravasation—Doxorubicin—muscle cancer	0.00721	0.00721	CcSEcCtD
Iohexol—Cardiac disorder—Vincristine—muscle cancer	0.00698	0.00698	CcSEcCtD
Iohexol—Bone disorder—Doxorubicin—muscle cancer	0.00697	0.00697	CcSEcCtD
Iohexol—Angiopathy—Vincristine—muscle cancer	0.00683	0.00683	CcSEcCtD
Iohexol—Mediastinal disorder—Vincristine—muscle cancer	0.00678	0.00678	CcSEcCtD
Iohexol—Renal failure—Etoposide—muscle cancer	0.00667	0.00667	CcSEcCtD
Iohexol—Malaise—Dactinomycin—muscle cancer	0.00661	0.00661	CcSEcCtD
Iohexol—Mental disorder—Vincristine—muscle cancer	0.00659	0.00659	CcSEcCtD
Iohexol—Pulmonary oedema—Methotrexate—muscle cancer	0.00647	0.00647	CcSEcCtD
Iohexol—Neck pain—Doxorubicin—muscle cancer	0.00637	0.00637	CcSEcCtD
Iohexol—Injection site reaction—Doxorubicin—muscle cancer	0.00626	0.00626	CcSEcCtD
Iohexol—Discomfort—Dactinomycin—muscle cancer	0.00617	0.00617	CcSEcCtD
Iohexol—Thrombophlebitis—Methotrexate—muscle cancer	0.0061	0.0061	CcSEcCtD
Iohexol—Urinary tract disorder—Etoposide—muscle cancer	0.00602	0.00602	CcSEcCtD
Iohexol—Urethral disorder—Etoposide—muscle cancer	0.00597	0.00597	CcSEcCtD
Iohexol—Eye disorder—Etoposide—muscle cancer	0.00569	0.00569	CcSEcCtD
Iohexol—Convulsion—Vincristine—muscle cancer	0.00567	0.00567	CcSEcCtD
Iohexol—Cardiac disorder—Etoposide—muscle cancer	0.00566	0.00566	CcSEcCtD
Iohexol—Flushing—Etoposide—muscle cancer	0.00566	0.00566	CcSEcCtD
Iohexol—Hypertension—Vincristine—muscle cancer	0.00565	0.00565	CcSEcCtD
Iohexol—Pulmonary oedema—Doxorubicin—muscle cancer	0.0056	0.0056	CcSEcCtD
Iohexol—Angiopathy—Etoposide—muscle cancer	0.00553	0.00553	CcSEcCtD
Iohexol—Immune system disorder—Etoposide—muscle cancer	0.0055	0.0055	CcSEcCtD
Iohexol—Mediastinal disorder—Etoposide—muscle cancer	0.00549	0.00549	CcSEcCtD
Iohexol—Anaphylactoid reaction—Methotrexate—muscle cancer	0.00545	0.00545	CcSEcCtD
Iohexol—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.00545	0.00545	CcSEcCtD
Iohexol—Anaphylactic shock—Vincristine—muscle cancer	0.00534	0.00534	CcSEcCtD
Iohexol—Thrombophlebitis—Doxorubicin—muscle cancer	0.00528	0.00528	CcSEcCtD
Iohexol—Nervous system disorder—Vincristine—muscle cancer	0.00524	0.00524	CcSEcCtD
Iohexol—Dysgeusia—Etoposide—muscle cancer	0.00519	0.00519	CcSEcCtD
Iohexol—Pain—Dactinomycin—muscle cancer	0.00512	0.00512	CcSEcCtD
Iohexol—Muscle spasms—Etoposide—muscle cancer	0.0051	0.0051	CcSEcCtD
Iohexol—Hypotension—Vincristine—muscle cancer	0.00499	0.00499	CcSEcCtD
Iohexol—Feeling abnormal—Dactinomycin—muscle cancer	0.00493	0.00493	CcSEcCtD
Iohexol—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00489	0.00489	CcSEcCtD
Iohexol—Musculoskeletal discomfort—Vincristine—muscle cancer	0.00487	0.00487	CcSEcCtD
Iohexol—Paraesthesia—Vincristine—muscle cancer	0.0048	0.0048	CcSEcCtD
Iohexol—Malaise—Etoposide—muscle cancer	0.00478	0.00478	CcSEcCtD
Iohexol—Body temperature increased—Dactinomycin—muscle cancer	0.00473	0.00473	CcSEcCtD
Iohexol—Abdominal pain—Dactinomycin—muscle cancer	0.00473	0.00473	CcSEcCtD
Iohexol—Anaphylactoid reaction—Doxorubicin—muscle cancer	0.00472	0.00472	CcSEcCtD
Iohexol—Loss of consciousness—Etoposide—muscle cancer	0.00466	0.00466	CcSEcCtD
Iohexol—Cough—Etoposide—muscle cancer	0.00463	0.00463	CcSEcCtD
Iohexol—Gastrointestinal disorder—Vincristine—muscle cancer	0.00461	0.00461	CcSEcCtD
Iohexol—Convulsion—Etoposide—muscle cancer	0.0046	0.0046	CcSEcCtD
Iohexol—Hypertension—Etoposide—muscle cancer	0.00458	0.00458	CcSEcCtD
Iohexol—Pain—Vincristine—muscle cancer	0.00457	0.00457	CcSEcCtD
Iohexol—Pain in extremity—Doxorubicin—muscle cancer	0.00457	0.00457	CcSEcCtD
Iohexol—Pancreatitis—Methotrexate—muscle cancer	0.00447	0.00447	CcSEcCtD
Iohexol—Discomfort—Etoposide—muscle cancer	0.00446	0.00446	CcSEcCtD
Iohexol—Hypersensitivity—Dactinomycin—muscle cancer	0.00441	0.00441	CcSEcCtD
Iohexol—Gastrointestinal pain—Vincristine—muscle cancer	0.00437	0.00437	CcSEcCtD
Iohexol—Confusional state—Etoposide—muscle cancer	0.00437	0.00437	CcSEcCtD
Iohexol—Cardiac arrest—Doxorubicin—muscle cancer	0.00434	0.00434	CcSEcCtD
Iohexol—Anaphylactic shock—Etoposide—muscle cancer	0.00433	0.00433	CcSEcCtD
Iohexol—Abdominal pain—Vincristine—muscle cancer	0.00422	0.00422	CcSEcCtD
Iohexol—Body temperature increased—Vincristine—muscle cancer	0.00422	0.00422	CcSEcCtD
Iohexol—Skin disorder—Etoposide—muscle cancer	0.00421	0.00421	CcSEcCtD
Iohexol—Diarrhoea—Dactinomycin—muscle cancer	0.00409	0.00409	CcSEcCtD
Iohexol—Hypotension—Etoposide—muscle cancer	0.00405	0.00405	CcSEcCtD
Iohexol—Muscular weakness—Doxorubicin—muscle cancer	0.00403	0.00403	CcSEcCtD
Iohexol—Renal failure—Methotrexate—muscle cancer	0.004	0.004	CcSEcCtD
Iohexol—Hypersensitivity—Vincristine—muscle cancer	0.00394	0.00394	CcSEcCtD
Iohexol—Paraesthesia—Etoposide—muscle cancer	0.00389	0.00389	CcSEcCtD
Iohexol—Pancreatitis—Doxorubicin—muscle cancer	0.00387	0.00387	CcSEcCtD
Iohexol—Dyspnoea—Etoposide—muscle cancer	0.00386	0.00386	CcSEcCtD
Iohexol—Somnolence—Etoposide—muscle cancer	0.00385	0.00385	CcSEcCtD
Iohexol—Vomiting—Dactinomycin—muscle cancer	0.0038	0.0038	CcSEcCtD
Iohexol—Rash—Dactinomycin—muscle cancer	0.00377	0.00377	CcSEcCtD
Iohexol—Gastrointestinal disorder—Etoposide—muscle cancer	0.00374	0.00374	CcSEcCtD
Iohexol—Pain—Etoposide—muscle cancer	0.0037	0.0037	CcSEcCtD
Iohexol—Diarrhoea—Vincristine—muscle cancer	0.00366	0.00366	CcSEcCtD
Iohexol—Urinary tract disorder—Methotrexate—muscle cancer	0.0036	0.0036	CcSEcCtD
Iohexol—Urethral disorder—Methotrexate—muscle cancer	0.00358	0.00358	CcSEcCtD
Iohexol—Feeling abnormal—Etoposide—muscle cancer	0.00357	0.00357	CcSEcCtD
Iohexol—Nausea—Dactinomycin—muscle cancer	0.00355	0.00355	CcSEcCtD
Iohexol—Gastrointestinal pain—Etoposide—muscle cancer	0.00354	0.00354	CcSEcCtD
Iohexol—Dizziness—Vincristine—muscle cancer	0.00353	0.00353	CcSEcCtD
Iohexol—Renal failure—Doxorubicin—muscle cancer	0.00346	0.00346	CcSEcCtD
Iohexol—Urticaria—Etoposide—muscle cancer	0.00344	0.00344	CcSEcCtD
Iohexol—Abdominal pain—Etoposide—muscle cancer	0.00342	0.00342	CcSEcCtD
Iohexol—Body temperature increased—Etoposide—muscle cancer	0.00342	0.00342	CcSEcCtD
Iohexol—Eye disorder—Methotrexate—muscle cancer	0.00341	0.00341	CcSEcCtD
Iohexol—Vomiting—Vincristine—muscle cancer	0.0034	0.0034	CcSEcCtD
Iohexol—Cardiac disorder—Methotrexate—muscle cancer	0.00339	0.00339	CcSEcCtD
Iohexol—Rash—Vincristine—muscle cancer	0.00337	0.00337	CcSEcCtD
Iohexol—Dermatitis—Vincristine—muscle cancer	0.00337	0.00337	CcSEcCtD
Iohexol—Headache—Vincristine—muscle cancer	0.00335	0.00335	CcSEcCtD
Iohexol—Angiopathy—Methotrexate—muscle cancer	0.00331	0.00331	CcSEcCtD
Iohexol—Immune system disorder—Methotrexate—muscle cancer	0.0033	0.0033	CcSEcCtD
Iohexol—Mediastinal disorder—Methotrexate—muscle cancer	0.00329	0.00329	CcSEcCtD
Iohexol—Bradycardia—Doxorubicin—muscle cancer	0.00322	0.00322	CcSEcCtD
Iohexol—Mental disorder—Methotrexate—muscle cancer	0.0032	0.0032	CcSEcCtD
Iohexol—Hypersensitivity—Etoposide—muscle cancer	0.00319	0.00319	CcSEcCtD
Iohexol—Erythema—Methotrexate—muscle cancer	0.00318	0.00318	CcSEcCtD
Iohexol—Nausea—Vincristine—muscle cancer	0.00317	0.00317	CcSEcCtD
Iohexol—Urinary tract disorder—Doxorubicin—muscle cancer	0.00312	0.00312	CcSEcCtD
Iohexol—Dysgeusia—Methotrexate—muscle cancer	0.00311	0.00311	CcSEcCtD
Iohexol—Urethral disorder—Doxorubicin—muscle cancer	0.0031	0.0031	CcSEcCtD
Iohexol—Pruritus—Etoposide—muscle cancer	0.00306	0.00306	CcSEcCtD
Iohexol—Diarrhoea—Etoposide—muscle cancer	0.00296	0.00296	CcSEcCtD
Iohexol—Eye disorder—Doxorubicin—muscle cancer	0.00295	0.00295	CcSEcCtD
Iohexol—Flushing—Doxorubicin—muscle cancer	0.00293	0.00293	CcSEcCtD
Iohexol—Cardiac disorder—Doxorubicin—muscle cancer	0.00293	0.00293	CcSEcCtD
Iohexol—Angiopathy—Doxorubicin—muscle cancer	0.00287	0.00287	CcSEcCtD
Iohexol—Malaise—Methotrexate—muscle cancer	0.00287	0.00287	CcSEcCtD
Iohexol—Dizziness—Etoposide—muscle cancer	0.00286	0.00286	CcSEcCtD
Iohexol—Immune system disorder—Doxorubicin—muscle cancer	0.00285	0.00285	CcSEcCtD
Iohexol—Mediastinal disorder—Doxorubicin—muscle cancer	0.00285	0.00285	CcSEcCtD
Iohexol—Arrhythmia—Doxorubicin—muscle cancer	0.00282	0.00282	CcSEcCtD
Iohexol—Cough—Methotrexate—muscle cancer	0.00277	0.00277	CcSEcCtD
Iohexol—Mental disorder—Doxorubicin—muscle cancer	0.00277	0.00277	CcSEcCtD
Iohexol—Convulsion—Methotrexate—muscle cancer	0.00275	0.00275	CcSEcCtD
Iohexol—Vomiting—Etoposide—muscle cancer	0.00275	0.00275	CcSEcCtD
Iohexol—Erythema—Doxorubicin—muscle cancer	0.00275	0.00275	CcSEcCtD
Iohexol—Rash—Etoposide—muscle cancer	0.00273	0.00273	CcSEcCtD
Iohexol—Dermatitis—Etoposide—muscle cancer	0.00273	0.00273	CcSEcCtD
Iohexol—Headache—Etoposide—muscle cancer	0.00271	0.00271	CcSEcCtD
Iohexol—Flatulence—Doxorubicin—muscle cancer	0.00271	0.00271	CcSEcCtD
Iohexol—Arthralgia—Methotrexate—muscle cancer	0.00271	0.00271	CcSEcCtD
Iohexol—Dysgeusia—Doxorubicin—muscle cancer	0.00269	0.00269	CcSEcCtD
Iohexol—Discomfort—Methotrexate—muscle cancer	0.00267	0.00267	CcSEcCtD
Iohexol—Muscle spasms—Doxorubicin—muscle cancer	0.00265	0.00265	CcSEcCtD
Iohexol—Confusional state—Methotrexate—muscle cancer	0.00261	0.00261	CcSEcCtD
Iohexol—Anaphylactic shock—Methotrexate—muscle cancer	0.00259	0.00259	CcSEcCtD
Iohexol—Nausea—Etoposide—muscle cancer	0.00257	0.00257	CcSEcCtD
Iohexol—Nervous system disorder—Methotrexate—muscle cancer	0.00254	0.00254	CcSEcCtD
Iohexol—Skin disorder—Methotrexate—muscle cancer	0.00252	0.00252	CcSEcCtD
Iohexol—Malaise—Doxorubicin—muscle cancer	0.00248	0.00248	CcSEcCtD
Iohexol—Syncope—Doxorubicin—muscle cancer	0.00247	0.00247	CcSEcCtD
Iohexol—Hypotension—Methotrexate—muscle cancer	0.00242	0.00242	CcSEcCtD
Iohexol—Loss of consciousness—Doxorubicin—muscle cancer	0.00242	0.00242	CcSEcCtD
Iohexol—Cough—Doxorubicin—muscle cancer	0.0024	0.0024	CcSEcCtD
Iohexol—Convulsion—Doxorubicin—muscle cancer	0.00238	0.00238	CcSEcCtD
Iohexol—Hypertension—Doxorubicin—muscle cancer	0.00238	0.00238	CcSEcCtD
Iohexol—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.00236	0.00236	CcSEcCtD
Iohexol—Arthralgia—Doxorubicin—muscle cancer	0.00234	0.00234	CcSEcCtD
Iohexol—Paraesthesia—Methotrexate—muscle cancer	0.00233	0.00233	CcSEcCtD
Iohexol—Discomfort—Doxorubicin—muscle cancer	0.00231	0.00231	CcSEcCtD
Iohexol—Dyspnoea—Methotrexate—muscle cancer	0.00231	0.00231	CcSEcCtD
Iohexol—Somnolence—Methotrexate—muscle cancer	0.00231	0.00231	CcSEcCtD
Iohexol—Confusional state—Doxorubicin—muscle cancer	0.00226	0.00226	CcSEcCtD
Iohexol—Anaphylactic shock—Doxorubicin—muscle cancer	0.00225	0.00225	CcSEcCtD
Iohexol—Gastrointestinal disorder—Methotrexate—muscle cancer	0.00224	0.00224	CcSEcCtD
Iohexol—Pain—Methotrexate—muscle cancer	0.00222	0.00222	CcSEcCtD
Iohexol—Shock—Doxorubicin—muscle cancer	0.00221	0.00221	CcSEcCtD
Iohexol—Nervous system disorder—Doxorubicin—muscle cancer	0.0022	0.0022	CcSEcCtD
Iohexol—Skin disorder—Doxorubicin—muscle cancer	0.00218	0.00218	CcSEcCtD
Iohexol—Feeling abnormal—Methotrexate—muscle cancer	0.00214	0.00214	CcSEcCtD
Iohexol—Gastrointestinal pain—Methotrexate—muscle cancer	0.00212	0.00212	CcSEcCtD
Iohexol—Hypotension—Doxorubicin—muscle cancer	0.0021	0.0021	CcSEcCtD
Iohexol—Urticaria—Methotrexate—muscle cancer	0.00206	0.00206	CcSEcCtD
Iohexol—Abdominal pain—Methotrexate—muscle cancer	0.00205	0.00205	CcSEcCtD
Iohexol—Body temperature increased—Methotrexate—muscle cancer	0.00205	0.00205	CcSEcCtD
Iohexol—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.00205	0.00205	CcSEcCtD
Iohexol—Paraesthesia—Doxorubicin—muscle cancer	0.00202	0.00202	CcSEcCtD
Iohexol—Dyspnoea—Doxorubicin—muscle cancer	0.002	0.002	CcSEcCtD
Iohexol—Somnolence—Doxorubicin—muscle cancer	0.002	0.002	CcSEcCtD
Iohexol—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.00194	0.00194	CcSEcCtD
Iohexol—Pain—Doxorubicin—muscle cancer	0.00192	0.00192	CcSEcCtD
Iohexol—Hypersensitivity—Methotrexate—muscle cancer	0.00191	0.00191	CcSEcCtD
Iohexol—Feeling abnormal—Doxorubicin—muscle cancer	0.00185	0.00185	CcSEcCtD
Iohexol—Gastrointestinal pain—Doxorubicin—muscle cancer	0.00184	0.00184	CcSEcCtD
Iohexol—Pruritus—Methotrexate—muscle cancer	0.00183	0.00183	CcSEcCtD
Iohexol—Urticaria—Doxorubicin—muscle cancer	0.00178	0.00178	CcSEcCtD
Iohexol—Body temperature increased—Doxorubicin—muscle cancer	0.00178	0.00178	CcSEcCtD
Iohexol—Abdominal pain—Doxorubicin—muscle cancer	0.00178	0.00178	CcSEcCtD
Iohexol—Diarrhoea—Methotrexate—muscle cancer	0.00177	0.00177	CcSEcCtD
Iohexol—Dizziness—Methotrexate—muscle cancer	0.00171	0.00171	CcSEcCtD
Iohexol—Hypersensitivity—Doxorubicin—muscle cancer	0.00165	0.00165	CcSEcCtD
Iohexol—Vomiting—Methotrexate—muscle cancer	0.00165	0.00165	CcSEcCtD
Iohexol—Rash—Methotrexate—muscle cancer	0.00164	0.00164	CcSEcCtD
Iohexol—Dermatitis—Methotrexate—muscle cancer	0.00163	0.00163	CcSEcCtD
Iohexol—Headache—Methotrexate—muscle cancer	0.00162	0.00162	CcSEcCtD
Iohexol—Pruritus—Doxorubicin—muscle cancer	0.00159	0.00159	CcSEcCtD
Iohexol—Nausea—Methotrexate—muscle cancer	0.00154	0.00154	CcSEcCtD
Iohexol—Diarrhoea—Doxorubicin—muscle cancer	0.00154	0.00154	CcSEcCtD
Iohexol—Dizziness—Doxorubicin—muscle cancer	0.00148	0.00148	CcSEcCtD
Iohexol—Vomiting—Doxorubicin—muscle cancer	0.00143	0.00143	CcSEcCtD
Iohexol—Rash—Doxorubicin—muscle cancer	0.00142	0.00142	CcSEcCtD
Iohexol—Dermatitis—Doxorubicin—muscle cancer	0.00141	0.00141	CcSEcCtD
Iohexol—Headache—Doxorubicin—muscle cancer	0.00141	0.00141	CcSEcCtD
Iohexol—Nausea—Doxorubicin—muscle cancer	0.00133	0.00133	CcSEcCtD
